Drugs that contain Elagolix Sodium

1. Drug name - ORILISSA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7419983 ABBVIE INC Gonadotropin-releasing hormone receptor antagonists and methods related thereto
Jul, 2024

(1 year, 9 months from now)

US7056927 ABBVIE INC Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
Sep, 2024

(1 year, 11 months from now)

CN100424078C ABBVIE INC As Gonadotropin-Releasing Hormone Receptor Antagonists And -2 - 4-Dione Derivatives
Jul, 2024

(1 year, 9 months from now)

CN1819829A ABBVIE INC As Gonadotropin-Releasing Hormone Receptor Antagonists And -2 - 4-Dione Derivatives
Jul, 2024

(1 year, 9 months from now)

IN200600072P1 ABBVIE INC Pyrimidine-2,4-Dione Derivatives As Gonadotropin-Releasing Hormone Receptor Antagonists
Jul, 2024

(1 year, 9 months from now)

IN312234B ABBVIE INC Pyrimidine-2, 4-Dione Based Compounds As Gonadotropin-Releasing Hormone Receptor Antagonists
Jul, 2024

(1 year, 9 months from now)

EP1646389A1 ABBVIE INC Pyrimidine-2,4-Dione Derivatives As Gonadotropin-Releasing Hormone Receptor Antagonists
Jul, 2024

(1 year, 9 months from now)

EP1646389B1 ABBVIE INC Pyrimidine-2,4-Dione Derivatives As Gonadotropin-Releasing Hormone Receptor Antagonists
Jul, 2024

(1 year, 9 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7176211 ABBVIE INC Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Jul, 2024

(1 year, 9 months from now)

US10537572 ABBVIE INC Methods of administering elagolix Sep, 2036

(13 years from now)

US10682351 ABBVIE INC Methods of administering elagolix Sep, 2036

(13 years from now)

Treatment: Management of moderate to severe pain associated with endometriosis; Management of moderate to severe pain associated with endometriosis using 150mg elagolix while co-administering rifampin; Management of moderate to severe pain associated with endometriosis using 150 mg elagolix while co-administering ketoconazole

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 150MG BASE TABLET;ORAL Prescription
EQ 200MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.